Concepts (252)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HSP70 Heat-Shock Proteins | 6 | 2017 | 25 | 2.960 |
Why?
|
| Insulin Resistance | 15 | 2019 | 449 | 2.890 |
Why?
|
| Liver | 9 | 2019 | 464 | 2.490 |
Why?
|
| Aging | 9 | 2020 | 881 | 2.230 |
Why?
|
| Fructose | 5 | 2019 | 9 | 2.070 |
Why?
|
| Endotoxemia | 4 | 2016 | 8 | 2.000 |
Why?
|
| Fatty Liver | 4 | 2014 | 66 | 1.800 |
Why?
|
| Adipose Tissue | 4 | 2020 | 327 | 1.630 |
Why?
|
| Animals | 45 | 2020 | 7297 | 1.590 |
Why?
|
| Whole-Body Irradiation | 3 | 2019 | 48 | 1.340 |
Why?
|
| Obesity | 7 | 2017 | 1063 | 1.290 |
Why?
|
| Muscle, Skeletal | 5 | 2016 | 494 | 1.220 |
Why?
|
| Blood Glucose | 13 | 2019 | 466 | 1.110 |
Why?
|
| Diabetes Mellitus, Experimental | 5 | 2011 | 51 | 0.970 |
Why?
|
| Insulin | 9 | 2014 | 346 | 0.920 |
Why?
|
| Glucose | 3 | 2017 | 163 | 0.780 |
Why?
|
| Liver Cirrhosis | 2 | 2019 | 75 | 0.750 |
Why?
|
| Subcutaneous Fat | 2 | 2017 | 42 | 0.710 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2019 | 27 | 0.700 |
Why?
|
| Female | 25 | 2020 | 18164 | 0.690 |
Why?
|
| Trans Fatty Acids | 2 | 2010 | 10 | 0.690 |
Why?
|
| Bacterial Infections | 1 | 2019 | 42 | 0.680 |
Why?
|
| Amniotic Fluid | 1 | 2019 | 84 | 0.670 |
Why?
|
| Metabolic Diseases | 1 | 2018 | 17 | 0.660 |
Why?
|
| Macaca fascicularis | 10 | 2017 | 389 | 0.660 |
Why?
|
| Bacteria | 1 | 2018 | 45 | 0.640 |
Why?
|
| Medicago sativa | 1 | 2017 | 2 | 0.630 |
Why?
|
| Hot Temperature | 2 | 2019 | 71 | 0.600 |
Why?
|
| Disease Models, Animal | 9 | 2020 | 980 | 0.600 |
Why?
|
| Lipids | 8 | 2016 | 209 | 0.600 |
Why?
|
| Body Weight | 10 | 2016 | 290 | 0.600 |
Why?
|
| Haplorhini | 5 | 2018 | 64 | 0.590 |
Why?
|
| Hydrotherapy | 1 | 2016 | 3 | 0.570 |
Why?
|
| Body Composition | 6 | 2019 | 365 | 0.560 |
Why?
|
| Muscles | 1 | 2016 | 53 | 0.550 |
Why?
|
| Intestinal Mucosa | 1 | 2016 | 64 | 0.550 |
Why?
|
| Sarcopenia | 1 | 2016 | 53 | 0.530 |
Why?
|
| Mitochondria | 1 | 2017 | 174 | 0.530 |
Why?
|
| Glucose Tolerance Test | 8 | 2016 | 125 | 0.530 |
Why?
|
| Diabetes Mellitus, Type 2 | 6 | 2015 | 1379 | 0.530 |
Why?
|
| Energy Metabolism | 1 | 2016 | 139 | 0.520 |
Why?
|
| Hypoglycemic Agents | 4 | 2011 | 176 | 0.520 |
Why?
|
| Physical Endurance | 1 | 2014 | 31 | 0.500 |
Why?
|
| Male | 22 | 2020 | 17807 | 0.500 |
Why?
|
| Glucose Intolerance | 2 | 2011 | 44 | 0.480 |
Why?
|
| Motor Activity | 1 | 2016 | 310 | 0.470 |
Why?
|
| Muscle Strength | 1 | 2014 | 139 | 0.470 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2013 | 14 | 0.460 |
Why?
|
| Streptozocin | 2 | 2011 | 8 | 0.420 |
Why?
|
| Prediabetic State | 2 | 2010 | 54 | 0.420 |
Why?
|
| Estrogens, Conjugated (USP) | 2 | 2009 | 125 | 0.410 |
Why?
|
| Isoflavones | 2 | 2008 | 65 | 0.400 |
Why?
|
| Weight Gain | 2 | 2013 | 108 | 0.400 |
Why?
|
| Overweight | 1 | 2013 | 256 | 0.400 |
Why?
|
| Soybean Proteins | 2 | 2008 | 64 | 0.400 |
Why?
|
| Dietary Fats | 2 | 2011 | 108 | 0.380 |
Why?
|
| Growth | 1 | 2010 | 7 | 0.380 |
Why?
|
| Growth Disorders | 1 | 2010 | 4 | 0.380 |
Why?
|
| Fluid Shifts | 1 | 2010 | 2 | 0.370 |
Why?
|
| PPAR gamma | 1 | 2010 | 45 | 0.370 |
Why?
|
| Sterol O-Acyltransferase | 1 | 2009 | 11 | 0.360 |
Why?
|
| Thiazolidinediones | 1 | 2010 | 47 | 0.360 |
Why?
|
| Menopause | 2 | 2013 | 86 | 0.360 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2010 | 88 | 0.350 |
Why?
|
| Mice, Inbred C57BL | 4 | 2019 | 711 | 0.350 |
Why?
|
| Adiponectin | 5 | 2017 | 103 | 0.340 |
Why?
|
| Hyperinsulinism | 1 | 2008 | 12 | 0.330 |
Why?
|
| Soybeans | 1 | 2008 | 25 | 0.330 |
Why?
|
| Estrogen Receptor Modulators | 1 | 2008 | 23 | 0.330 |
Why?
|
| Phytotherapy | 1 | 2008 | 38 | 0.320 |
Why?
|
| Pregnancy | 4 | 2020 | 815 | 0.320 |
Why?
|
| Macaca mulatta | 3 | 2019 | 322 | 0.310 |
Why?
|
| Plant Extracts | 1 | 2008 | 60 | 0.310 |
Why?
|
| Dose-Response Relationship, Radiation | 2 | 2019 | 76 | 0.310 |
Why?
|
| Intra-Abdominal Fat | 2 | 2020 | 61 | 0.310 |
Why?
|
| Atherosclerosis | 2 | 2011 | 693 | 0.300 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2011 | 641 | 0.290 |
Why?
|
| Insulin-Secreting Cells | 3 | 2011 | 53 | 0.280 |
Why?
|
| Animal Feed | 3 | 2019 | 14 | 0.280 |
Why?
|
| Hyperglycemia | 3 | 2011 | 82 | 0.280 |
Why?
|
| Carbohydrates | 1 | 2005 | 6 | 0.270 |
Why?
|
| Hormones | 1 | 2005 | 19 | 0.270 |
Why?
|
| Diet, Fat-Restricted | 2 | 2017 | 30 | 0.260 |
Why?
|
| Iron | 2 | 2019 | 113 | 0.260 |
Why?
|
| Primates | 3 | 2020 | 100 | 0.240 |
Why?
|
| Homeostasis | 2 | 2015 | 127 | 0.240 |
Why?
|
| Endpoint Determination | 3 | 2013 | 19 | 0.230 |
Why?
|
| Cholesterol, Dietary | 2 | 2014 | 36 | 0.230 |
Why?
|
| Diterpenes | 2 | 2014 | 15 | 0.230 |
Why?
|
| Lipid Metabolism | 2 | 2013 | 100 | 0.200 |
Why?
|
| Mice | 4 | 2019 | 2368 | 0.200 |
Why?
|
| Peanut Hypersensitivity | 1 | 2020 | 1 | 0.190 |
Why?
|
| Allergens | 1 | 2020 | 16 | 0.190 |
Why?
|
| Adaptation, Physiological | 1 | 2020 | 51 | 0.190 |
Why?
|
| Energy Intake | 2 | 2013 | 120 | 0.190 |
Why?
|
| Immunoglobulin E | 1 | 2020 | 47 | 0.180 |
Why?
|
| Lipolysis | 1 | 2019 | 17 | 0.180 |
Why?
|
| Iron, Dietary | 1 | 2019 | 11 | 0.180 |
Why?
|
| Immunoglobulin G | 1 | 2020 | 104 | 0.180 |
Why?
|
| Fibrosis | 1 | 2019 | 102 | 0.180 |
Why?
|
| Adiposity | 2 | 2010 | 191 | 0.170 |
Why?
|
| Immunoglobulins | 1 | 2018 | 12 | 0.170 |
Why?
|
| Disease Susceptibility | 1 | 2018 | 53 | 0.160 |
Why?
|
| Cattle | 1 | 2018 | 100 | 0.160 |
Why?
|
| Area Under Curve | 2 | 2016 | 85 | 0.160 |
Why?
|
| Monkey Diseases | 2 | 2010 | 18 | 0.160 |
Why?
|
| Fasting | 2 | 2016 | 93 | 0.160 |
Why?
|
| Colon | 1 | 2018 | 56 | 0.160 |
Why?
|
| Stress, Physiological | 2 | 2017 | 44 | 0.160 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 26 | 0.160 |
Why?
|
| Administration, Intranasal | 1 | 2017 | 30 | 0.160 |
Why?
|
| Mass Spectrometry | 1 | 2017 | 99 | 0.150 |
Why?
|
| Fluorescent Dyes | 1 | 2017 | 45 | 0.150 |
Why?
|
| Macrophage Activation | 1 | 2017 | 9 | 0.150 |
Why?
|
| Bacteriuria | 1 | 2017 | 4 | 0.150 |
Why?
|
| Copper | 1 | 2017 | 11 | 0.150 |
Why?
|
| Proteomics | 1 | 2017 | 92 | 0.150 |
Why?
|
| Host-Pathogen Interactions | 1 | 2017 | 30 | 0.150 |
Why?
|
| Urinary Tract | 1 | 2017 | 21 | 0.150 |
Why?
|
| Time Factors | 3 | 2020 | 2001 | 0.150 |
Why?
|
| Bacterial Translocation | 1 | 2016 | 8 | 0.140 |
Why?
|
| Gamma Rays | 1 | 2016 | 24 | 0.140 |
Why?
|
| Intestines | 1 | 2016 | 54 | 0.140 |
Why?
|
| Cardiovascular System | 1 | 2016 | 39 | 0.140 |
Why?
|
| Adipocytes | 2 | 2014 | 79 | 0.140 |
Why?
|
| Pedigree | 2 | 2013 | 133 | 0.130 |
Why?
|
| Macrophages | 1 | 2017 | 188 | 0.130 |
Why?
|
| Myocardium | 1 | 2016 | 170 | 0.130 |
Why?
|
| Heart | 1 | 2016 | 161 | 0.130 |
Why?
|
| Triglycerides | 3 | 2010 | 214 | 0.130 |
Why?
|
| Risk | 1 | 2015 | 289 | 0.120 |
Why?
|
| Random Allocation | 1 | 2014 | 213 | 0.120 |
Why?
|
| Lipoproteins | 2 | 2014 | 82 | 0.120 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2014 | 50 | 0.120 |
Why?
|
| Metagenome | 1 | 2013 | 5 | 0.120 |
Why?
|
| Models, Animal | 1 | 2014 | 160 | 0.120 |
Why?
|
| Lipoproteins, LDL | 2 | 2013 | 77 | 0.120 |
Why?
|
| Cercopithecinae | 1 | 2013 | 2 | 0.110 |
Why?
|
| Diet | 2 | 2013 | 354 | 0.110 |
Why?
|
| Piperidines | 2 | 2010 | 125 | 0.110 |
Why?
|
| Hyperthermia, Induced | 1 | 2014 | 235 | 0.100 |
Why?
|
| Women's Health | 1 | 2013 | 226 | 0.100 |
Why?
|
| Arginine | 1 | 2011 | 17 | 0.100 |
Why?
|
| Superoxides | 1 | 2011 | 17 | 0.100 |
Why?
|
| Heat Stress Disorders | 1 | 2011 | 9 | 0.100 |
Why?
|
| Genotype | 1 | 2013 | 735 | 0.100 |
Why?
|
| Arteries | 1 | 2011 | 60 | 0.100 |
Why?
|
| Triazines | 1 | 2010 | 3 | 0.100 |
Why?
|
| Azetidines | 1 | 2010 | 8 | 0.100 |
Why?
|
| Anti-Obesity Agents | 1 | 2010 | 6 | 0.100 |
Why?
|
| Lactation | 1 | 2010 | 14 | 0.090 |
Why?
|
| Phosphorylation | 1 | 2011 | 225 | 0.090 |
Why?
|
| Milk, Human | 1 | 2010 | 14 | 0.090 |
Why?
|
| Pancreas | 1 | 2011 | 79 | 0.090 |
Why?
|
| Body Water | 1 | 2010 | 8 | 0.090 |
Why?
|
| Propionates | 1 | 2010 | 3 | 0.090 |
Why?
|
| DNA-Binding Proteins | 1 | 2011 | 142 | 0.090 |
Why?
|
| Extracellular Fluid | 1 | 2010 | 11 | 0.090 |
Why?
|
| Extracellular Space | 1 | 2010 | 25 | 0.090 |
Why?
|
| Abdominal Fat | 1 | 2010 | 46 | 0.090 |
Why?
|
| C-Peptide | 2 | 2011 | 25 | 0.090 |
Why?
|
| Animals, Newborn | 1 | 2010 | 111 | 0.090 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2010 | 51 | 0.090 |
Why?
|
| Transcription Factors | 1 | 2011 | 172 | 0.090 |
Why?
|
| PPAR alpha | 1 | 2010 | 29 | 0.090 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2010 | 80 | 0.090 |
Why?
|
| Analysis of Variance | 1 | 2011 | 454 | 0.090 |
Why?
|
| Absorptiometry, Photon | 1 | 2010 | 129 | 0.090 |
Why?
|
| Islets of Langerhans | 1 | 2010 | 74 | 0.090 |
Why?
|
| Middle Aged | 2 | 2014 | 10829 | 0.090 |
Why?
|
| Apoptosis | 1 | 2011 | 337 | 0.080 |
Why?
|
| Humans | 6 | 2019 | 29093 | 0.080 |
Why?
|
| Seeds | 1 | 2008 | 9 | 0.080 |
Why?
|
| Thyroxine | 1 | 2008 | 16 | 0.080 |
Why?
|
| European Continental Ancestry Group | 1 | 2013 | 1131 | 0.080 |
Why?
|
| Premenopause | 1 | 2008 | 38 | 0.080 |
Why?
|
| Positron-Emission Tomography | 1 | 2009 | 172 | 0.080 |
Why?
|
| Cholesterol, HDL | 1 | 2008 | 165 | 0.080 |
Why?
|
| Body Size | 1 | 2007 | 31 | 0.080 |
Why?
|
| Medroxyprogesterone Acetate | 1 | 2007 | 89 | 0.070 |
Why?
|
| Phenotype | 2 | 2020 | 629 | 0.070 |
Why?
|
| Pregnancy Complications | 1 | 2007 | 80 | 0.070 |
Why?
|
| Sex Characteristics | 1 | 2007 | 167 | 0.070 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2007 | 182 | 0.070 |
Why?
|
| Fructosamine | 1 | 2005 | 5 | 0.070 |
Why?
|
| African Americans | 1 | 2013 | 1373 | 0.070 |
Why?
|
| Estrone | 1 | 2005 | 7 | 0.070 |
Why?
|
| Androstenedione | 1 | 2005 | 5 | 0.070 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2005 | 8 | 0.070 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2005 | 19 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2005 | 129 | 0.070 |
Why?
|
| Ovariectomy | 1 | 2005 | 147 | 0.060 |
Why?
|
| Estradiol | 1 | 2005 | 118 | 0.060 |
Why?
|
| Gene Expression Regulation | 2 | 2019 | 481 | 0.060 |
Why?
|
| Inflammation | 2 | 2019 | 507 | 0.060 |
Why?
|
| Aged | 1 | 2014 | 9487 | 0.050 |
Why?
|
| Maternal Age | 1 | 2020 | 8 | 0.050 |
Why?
|
| Histamine | 1 | 2020 | 3 | 0.050 |
Why?
|
| Anaphylaxis | 1 | 2020 | 11 | 0.050 |
Why?
|
| Cell Wall | 1 | 2019 | 5 | 0.050 |
Why?
|
| Teichoic Acids | 1 | 2019 | 7 | 0.050 |
Why?
|
| Caenorhabditis elegans | 1 | 2019 | 19 | 0.050 |
Why?
|
| Hep G2 Cells | 1 | 2019 | 23 | 0.050 |
Why?
|
| Risk Factors | 1 | 2007 | 3531 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2019 | 107 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2011 | 519 | 0.040 |
Why?
|
| Skin | 1 | 2020 | 203 | 0.040 |
Why?
|
| Reference Standards | 1 | 2017 | 30 | 0.040 |
Why?
|
| Databases, Genetic | 1 | 2017 | 35 | 0.040 |
Why?
|
| Ceruloplasmin | 1 | 2017 | 5 | 0.040 |
Why?
|
| Ions | 1 | 2017 | 11 | 0.040 |
Why?
|
| Disease Progression | 1 | 2019 | 572 | 0.040 |
Why?
|
| Weight Loss | 2 | 2010 | 413 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2017 | 126 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2020 | 804 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2019 | 666 | 0.030 |
Why?
|
| Cognition | 1 | 2019 | 526 | 0.030 |
Why?
|
| Hypertrophy | 1 | 2014 | 26 | 0.030 |
Why?
|
| Cell Size | 1 | 2014 | 32 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2014 | 77 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2014 | 20 | 0.030 |
Why?
|
| Heat-Shock Proteins | 1 | 2014 | 28 | 0.030 |
Why?
|
| Fever | 1 | 2014 | 56 | 0.030 |
Why?
|
| Animal Nutritional Physiological Phenomena | 1 | 2013 | 9 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 366 | 0.030 |
Why?
|
| Cholesterol | 1 | 2014 | 229 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2016 | 562 | 0.030 |
Why?
|
| Catalase | 1 | 2011 | 16 | 0.020 |
Why?
|
| Diet, Atherogenic | 1 | 2011 | 61 | 0.020 |
Why?
|
| Superoxide Dismutase | 1 | 2011 | 47 | 0.020 |
Why?
|
| Ferritins | 1 | 2011 | 46 | 0.020 |
Why?
|
| Cell Division | 1 | 2011 | 97 | 0.020 |
Why?
|
| Heme Oxygenase-1 | 1 | 2011 | 33 | 0.020 |
Why?
|
| Sex Factors | 1 | 2013 | 631 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 152 | 0.020 |
Why?
|
| Amyloidosis | 1 | 2010 | 10 | 0.020 |
Why?
|
| Lipoproteins, HDL | 1 | 2013 | 247 | 0.020 |
Why?
|
| Dogs | 1 | 2010 | 117 | 0.020 |
Why?
|
| Leptin | 1 | 2010 | 66 | 0.020 |
Why?
|
| Eating | 1 | 2010 | 73 | 0.020 |
Why?
|
| Fluorobenzenes | 1 | 2009 | 19 | 0.020 |
Why?
|
| Fluorine Radioisotopes | 1 | 2009 | 21 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2011 | 223 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2010 | 159 | 0.020 |
Why?
|
| Reference Values | 1 | 2009 | 224 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2010 | 232 | 0.020 |
Why?
|
| Exercise | 1 | 2014 | 591 | 0.020 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2008 | 3 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2008 | 58 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2010 | 747 | 0.020 |
Why?
|
| Cercopithecidae | 1 | 2006 | 10 | 0.020 |
Why?
|
| Rats | 1 | 2010 | 1604 | 0.020 |
Why?
|